SCHEMBL7077633

SCHEMBL7077633

COC(=O)CC(CSc1ccc(C(=O)c2ccccc2[N+](=O)[O-])cc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.40
ALDH1A1 P00352 7/20 0.39
HPGD P15428 2/20 0.39
GAA P10253 2/20 0.39
POLB P06746 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CDC25B P30305 1/20 0.38
CTSD P07339 1/20 0.38
RAB9A P51151 3/20 0.37
LMNA P02545 1/20 0.37
GLA P06280 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 2/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
BCL2L1 Q07817 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7079094 0.82 MEN1 (0.47) ALDH1A1POLBMEN1KMT2ARAB9A
SCHEMBL7073776 0.79 ALDH1A1 (0.51) ALDH1A1HPGDKMT2ALMNAMAPT
SCHEMBL7079205 0.77 ALDH1A1 (0.47) ALDH1A1KMT2ALMNAL3MBTL1
SCHEMBL7077638 0.76 ALDH1A1 (0.46) SMN1; SMN2ALDH1A1GAAPOLBMEN1
Fluoride SCHEMBL28190274 0.71 ALDH1A1 (0.59) ALDH1A1HPGDGAAPOLBCDC25B
Methyl Carbamate SCHEMBL28105575 0.70 CTSD (0.53) SMN1; SMN2ALDH1A1HPGDGAAPOLB
Methylsulfanylmethane SCHEMBL28313804 0.70 ALDH1A1 (0.55) ALDH1A1HPGDGAAPOLBCDC25B
SCHEMBL11301800 0.69 MAPK1 (0.59) ALDH1A1HPGDGAAPOLBCDC25B
Methyl Alcohol SCHEMBL27551657 0.69 ALDH1A1 (0.56) ALDH1A1HPGDGAAPOLBCDC25B
Fluoride SCHEMBL28067846 0.69 ALDH1A1 (0.57) ALDH1A1HPGDGAAPOLBCDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003059872-A1 AVB3 AND AVB5 INTEGRIN ANTAGONISTS AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH AVB3 AND AVB5 INTEGRINS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-24 WO disclosed